Indian stocks are relatively inexpensive at this moment and have an outstanding long-term future. Read the full analysis here.
In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in clinics and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results